1. Martinez-Fernandez De La Camara, Cristina, Cehajic-Kapetanovic, Jasmina, MacLaren, Robert E. 2019. RPGR gene therapy presents challenges in cloning the coding sequence. In Expert opinion on biological therapy, 20, 63-71. doi:10.1080/14712598.2020.1680635. https://pubmed.ncbi.nlm.nih.gov/31612744/
2. Cehajic-Kapetanovic, Jasmina, Xue, Kanmin, Martinez-Fernandez de la Camara, Cristina, Stanga, Paulo E, MacLaren, Robert E. 2020. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. In Nature medicine, 26, 354-359. doi:10.1038/s41591-020-0763-1. https://pubmed.ncbi.nlm.nih.gov/32094925/
3. Awadh Hashem, Shaima, Georgiou, Michalis, Ali, Robin R, Michaelides, Michel. 2023. RPGR-Related Retinopathy: Clinical Features, Molecular Genetics, and Gene Replacement Therapy. In Cold Spring Harbor perspectives in medicine, 13, . doi:10.1101/cshperspect.a041280. https://pubmed.ncbi.nlm.nih.gov/37188525/
4. Gumerson, Jessica D, Alsufyani, Amal, Yu, Wenhan, Wu, Zhijian, Li, Tiansen. 2021. Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing. In Gene therapy, 29, 81-93. doi:10.1038/s41434-021-00258-6. https://pubmed.ncbi.nlm.nih.gov/34257417/